Japan’s Health Ministry Files Complaint against Novartis

NovartisAccording to a latest report, the Japan's health ministry has recently filed a complaint with Tokyo prosecutors against Novartis (NOVN) AG.

Novartis is a leading company in the research and development of products to protect and improve health and well-being.

It has been revealed by Soitces that the company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care, and animal health.

It has been revealed by the sources that Japan's health ministry seeks a criminal investigation of the company as it is believed that the company has possibly breached advertising rules and regulations.

Sources said it is suspected that the company has breached the rules of advertising with its Diovan hypertension drug.

It has been revealed by the sources that the company is accused of exaggerating Diovan's effectiveness in marketing materials.

It has been confessed by the Basel, Switzerland-based Company in a statement that it will try its level best to provide full cooperation to the Japanese authorities.

A ministry panel has said in the month of September that without any genuine evidence Novartis has promoted Diovan as a treatment for cutting stroke risks. It has also been claimed by the ministry panel that this sort of a breach can lead to fines and jail terms.